Proposed Information Collection Activity; Comment Request, 68818-68819 [06-9413]
Download as PDF
<![CDATA[
68818
Federal Register / Vol. 71, No. 228 / Tuesday, November 28, 2006 / Notices
liquidity, credit, and operational risks
related to Fedwire funds transfers,
especially late-day transfers. The paper
also requested views on potential
changes in market practices, operations,
and the Board’s Payments System Risk
policy that could reduce one or more of
these risks. The consultation paper
stated that comments must be submitted
on or before December 15, 2006.
The Board received a letter from an
industry group, whose members include
a number of large U.S. depository
institutions and foreign banking
organizations, requesting, on behalf of
that group and its members, an
extension of the comment period. Based
on interactions the Board has had with
this group, its members, and other
interested parties, the Board believes
that an extension would enable these
organizations to investigate further the
drivers of their liquidity management
practices and late-day Fedwire funds
transfers. The extension will also allow
a range of organizations more time to
provide a thorough response to the
consultation paper. Consequently, the
Board has decided to extend the
comment period on the consultation
paper by 90 days. The comment period
will now end March 15, 2007.
By order of the Board of Governors of the
Federal Reserve System, acting through the
Secretary of the Board under delegated
authority, November 21, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E6–20048 Filed 11–27–06; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator for
Health Information Technology;
American Health Information
Community Meeting
Administration for Children and
Families
ACTION:
Announcement of meeting.
This notice announces the
tenth meeting of the American Health
Information Community in accordance
with the Federal Advisory Committee
Act (Pub. L. No. 92–463, 5 U.S.C., App.)
The American Health Information
Community will advise the Secretary
and recommend specific actions to
achieve a common interoperability
framework for health information
technology (IT).
DATES: December 12, 2006, from 8:30
a.m. to 12 p.m.
ADDRESSES: Hubert H. Humphrey
building (200 Independence Avenue,
SW., Washington, DC 20201),
Conference Room 800.
FOR FURTHER INFORMATION CONTACT: Visit
https://www.hhs.gov/healthit/ahic.html.
SUPPLEMENTARY INFORMATION: The
Community will discuss state-federal
health information exchange technology
and coordination, the development of
proto-use cases, and an update on the
Personalized Healthcare Workgroup.
A Web cast of the Community
meeting will be available on the NIH
Web site at: https://
www.videocast.nih.gov/.
If you have special needs for the
meeting, please contact (202) 690–7151.
SUMMARY:
Dated: November 16, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator for Health Information
Technology.
[FR Doc. 06–9430 Filed 11–27–06; 8:45 am]
BILLING CODE 4150–24–M
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
Title: Annual Maintenance-of-Effort
(MOE) Report.
OMB No.: 0970–0248.
Description: The Administration for
Children and Families (ACF) is
requesting a three-year extension of the
ACF–204 (Annual MOE Report). The
report is used to collect descriptive
program characteristics information on
the programs operated by States and
Territories in association with their
Temporary Assistance for Needy
Families (TANF) programs. All State
and Territory expenditures claimed
toward States’ and Territories’ MOE
requirements must be appropriate, i.e.,
meet all applicable MOE requirements.
The Annual MOE Report provides the
ability to learn about and to monitor the
nature of State and Territory
expenditures used to meet State’s and
Territories’ MOE requirements, and it is
an important source of information
about the different ways that States and
Territories are using their resources to
help families attain and maintain selfsufficiency. In addition, the report is
used to obtain State and Territory
program characteristics for ACF’s
annual report to Congress, and the
report serves as a useful resource to use
in Congressional hearings about how
TANF programs are evolving, in
assessing State and Territory MOE
expenditures, and in assessing the need
for legislative changes.
Respondents: The 50 States of the
United States, the District of Columbia,
Guam, Puerto Rico, and the Virgin
Islands.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
ACF–204 ..........................................................................................................
ycherry on PROD1PC61 with NOTICES
Instrument
54
1
128
6,912
Estimated Total Annual Burden
Hours: 6,912.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
VerDate Aug<31>2005
15:42 Nov 27, 2006
Jkt 211001
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
rsargis@acf.hhs.gov. All requests should
be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
E:\FR\FM\28NON1.SGM
28NON1
Federal Register / Vol. 71, No. 228 / Tuesday, November 28, 2006 / Notices
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: November 21, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06–9413 Filed 11–27–06; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2006N–0465]
Improving Patient Safety by Enhancing
the Container Labeling for Parenteral
Infusion Drug Products; Public
Meeting
AGENCY:
Food and Drug Administration,
HHS.
reached by Metro using the Medical
Center Station on the red line. Parking
is limited at NIH, so Metro use is
recommended. For directions and
visitor information, see https://
www.nih.gov/about/visitor/index.htm.
(FDA has verified the Web site address,
but FDA is not responsible for any
subsequent changes to the Web site after
this document publishes in the Federal
Register).
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Submit electronic comments
to https://www.fda.gov/dockets/
ecomments. Submit written or
electronic requests to speak at the
meeting to the information contact.
Transcripts of the hearing will be
available for review at the Division of
Dockets Management and on the
Internet at https://www.fda.gov/cder/
meeting/parenteralllabeling.htm.
FOR FURTHER INFORMATION CONTACT: Jean
Chung, Center for Drug Evaluation and
Research (HFD–400), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–2380, email: jean.chung@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
ACTION:
I. Background
SUMMARY: The Food and Drug
Administration (FDA) is announcing a
public meeting on improving patient
safety by enhancing the container
labeling for parenteral infusion drug
products. This will be a 1-day workshop
involving FDA staff and representatives
of the United States Pharmacopeia
(USP) and the Institute for Safe
Medication Practices (ISMP). The
purpose of the meeting is to explore
how labels on intravenous (IV) drug
products could be designed to minimize
medication errors. Design issues include
placement, style and type of
information, the need for standard
expression of strength, quantity of
information, and use of color on the
label.
DATES: The public meeting will be held
on January 11, 2007, from 8 a.m. to 4
p.m. Submit written or electronic
requests to speak by December 28, 2006.
Written or electronic comments to the
docket will be accepted until April 12,
2007.
ADDRESSES: The public meeting will be
held at the Lister Hill Center
Auditorium (the center), National
Institutes of Health (NIH) campus, 9000
Rockville Pike, bldg. 38A, Bethesda, MD
20815, 301–496–4441. The center can be
Premixed large volume parenterals
(LVPs) and small volume parenterals
(SVPs) in ready to infuse final dosage
forms are designed to deliver premixed
drugs (e.g., antibiotics, electrolyte
solutions, pain management infusions).
Premixed LVPs and SVPs improve
standardized drug delivery and can
reduce the potential for medication
errors by reducing the steps required in
IV preparation and the additional
quality control checks needed by the
pharmacy prior to dispensing and
administering the product. Premixed
LVPs and SVPs: (1) Provide an end
product that is labeled with the
ingredients including a product
identification code (e.g., bar code), (2)
promote a sterile environment, and (3)
maintain accurate concentration within
a closed system. According to the USP,
‘‘the designation large-volume
intravenous solution applies to a singledose injection that is intended for
intravenous use and is packaged in
containers labeled as containing more
than 100 mL. The designation smallvolume injection applies to an injection
that is packaged in containers labeled as
containing 100 mL or less.’’
Although premixed LVPs and SVPs
can reduce the potential for mixing
errors, the labels and labeling of these
products, as well as base solutions of
ycherry on PROD1PC61 with NOTICES
Notice of public meeting;
request for comments.
VerDate Aug<31>2005
15:42 Nov 27, 2006
Jkt 211001
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
68819
LVPs and SVPs without drug, have been
documented as contributing to
medication errors in both acute care and
ambulatory settings, as well as in home
care settings. The types of errors
reported involve the inability to
distinguish different drug products, as
well as different strengths of drug
products, because the containers look
similar and use similar colors for label
text. In addition to these visual
similarities, manufacturers may label
the same drug product with varying
units of measure (e.g., micrograms
versus milligrams), which has also
contributed to error. There is also a large
amount of information that is placed on
the container label that can not only
crowd the label but can distract from the
most important information, that is, the
proprietary and established names and
product strength.Thus, we would like to
explore how current IV labels should be
designed to minimize medication errors.
II. Scope of the Public Meeting
The public meeting is intended to
explore how IV labels could be designed
to minimize medication errors. Design
issues include placement, style and type
of information, the need for standard
expression of strength, quantity of
information, and use of color on the
label.
This 1-day workshop will assemble
drug safety experts, patient advocates,
government experts, and
pharmaceutical and device
manufacturers to discuss outstanding
regulatory, technological, and resource
issues. Other interested constituencies
(e.g., patient advocacy and education
groups, pharmaceutical sponsors,
general public) will have an opportunity
to provide input during the question
and comment periods. FDA is interested
in obtaining public comment and
encourages all interested parties to
submit requests to speak at the meeting
or to submit written or electronic
comments to the docket. (See sections
III. and IV. of this document.)
The meeting will include an overview
of FDA and USP requirements,
presentations from the clinical
perspective (nurse and pharmacist) and
industry perspective, and a series of
panel discussions. The following topics
will be discussed: Look-alike containers,
confusing labels on sterile water
containers, container label
requirements, and the lack of
standardized expression of medication
concentration on labels. Questions that
will be considered during this public
meeting include, but are not limited to,
the following:
1. What are the best solutions to
differentiate look-alike container labels
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 71, Number 228 (Tuesday, November 28, 2006)]
[Notices]
[Pages 68818-68819]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9413]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Proposed Projects:
Title: Annual Maintenance-of-Effort (MOE) Report.
OMB No.: 0970-0248.
Description: The Administration for Children and Families (ACF) is
requesting a three-year extension of the ACF-204 (Annual MOE Report).
The report is used to collect descriptive program characteristics
information on the programs operated by States and Territories in
association with their Temporary Assistance for Needy Families (TANF)
programs. All State and Territory expenditures claimed toward States'
and Territories' MOE requirements must be appropriate, i.e., meet all
applicable MOE requirements. The Annual MOE Report provides the ability
to learn about and to monitor the nature of State and Territory
expenditures used to meet State's and Territories' MOE requirements,
and it is an important source of information about the different ways
that States and Territories are using their resources to help families
attain and maintain self-sufficiency. In addition, the report is used
to obtain State and Territory program characteristics for ACF's annual
report to Congress, and the report serves as a useful resource to use
in Congressional hearings about how TANF programs are evolving, in
assessing State and Territory MOE expenditures, and in assessing the
need for legislative changes.
Respondents: The 50 States of the United States, the District of
Columbia, Guam, Puerto Rico, and the Virgin Islands.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Number of responses per hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
ACF-204..................................... 54 1 128 6,912
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 6,912.
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: rsargis@acf.hhs.gov. All requests should be identified by the
title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have
[[Page 68819]]
practical utility; (b) the accuracy of the agency's estimate of the
burden of the proposed collection of information; (c) the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Consideration will be given to
comments and suggestions submitted within 60 days of this publication.
Dated: November 21, 2006.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 06-9413 Filed 11-27-06; 8:45 am]
BILLING CODE 4184-01-M
